written on 02.06.2014

AZ's Zoladex could stave off early menopause in breast cancer patients


Now that the Pfizer takeover AstraZeneca fought to avoid is on the rocks–at least for the time being–the pressure's on the British drugmaker to deliver strong growth on its own. And while much of the attention is focused on its pipeline, leading cancer drug Zoladex may be able to chip in, too, with new data suggesting it could help prevent infertility in some breast cancer patients receiving chemo.